Literature DB >> 21099444

Effectiveness of haemophilus influenzae type B conjugate vaccine for prevention of meningitis in Senegal.

Jessica A Fleming1, Yakou Dieye, Ousseynou Ba, Boniface Mutombo wa Mutombo, Ndiouga Diallo, Pape Coumba Faye, Mamadou Ba, Moussa Fafa Cisse, Aissatou Gaye Diallo, Mady Ba, Mary P E Slack, Noel S Weiss.   

Abstract

A total of 24 cases of hospitalized, laboratory-confirmed Haemophilus influenzae type b (Hib) meningitis were identified through a regional pediatric bacterial meningitis surveillance system. Each case was matched by age and residence to 4 neighborhood controls. The adjusted vaccine effectiveness for ≥ 2 doses was 95.8% (95% confidence interval, 67.9%-99.4%). Hib vaccine appears to be highly effective in preventing Hib meningitis in Senegal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21099444     DOI: 10.1097/INF.0b013e318203aaa0

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

Review 1.  The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review.

Authors:  Stephanie Davis; Daniel Feikin; Hope L Johnson
Journal:  BMC Public Health       Date:  2013-09-17       Impact factor: 3.295

Review 2.  Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

Authors:  Jennifer R Verani; Abdullah H Baqui; Claire V Broome; Thomas Cherian; Cheryl Cohen; Jennifer L Farrar; Daniel R Feikin; Michelle J Groome; Rana A Hajjeh; Hope L Johnson; Shabir A Madhi; Kim Mulholland; Katherine L O'Brien; Umesh D Parashar; Manish M Patel; Laura C Rodrigues; Mathuram Santosham; J Anthony Scott; Peter G Smith; Halvor Sommerfelt; Jacqueline E Tate; J Chris Victor; Cynthia G Whitney; Anita K Zaidi; Elizabeth R Zell
Journal:  Vaccine       Date:  2017-04-22       Impact factor: 3.641

Review 3.  Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.

Authors:  Jennifer R Verani; Abdullah H Baqui; Claire V Broome; Thomas Cherian; Cheryl Cohen; Jennifer L Farrar; Daniel R Feikin; Michelle J Groome; Rana A Hajjeh; Hope L Johnson; Shabir A Madhi; Kim Mulholland; Katherine L O'Brien; Umesh D Parashar; Manish M Patel; Laura C Rodrigues; Mathuram Santosham; J Anthony Scott; Peter G Smith; Halvor Sommerfelt; Jacqueline E Tate; J Chris Victor; Cynthia G Whitney; Anita K Zaidi; Elizabeth R Zell
Journal:  Vaccine       Date:  2017-04-23       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.